Fed. Circ. To Reconsider Tafas V. Doll

Law360, New York (July 7, 2009, 12:00 AM EDT) -- A federal appeals court has decided to rethink a March ruling that restored most of the U.S. Patent and Trademark Office’s controversial rules aimed at curtailing prosecution abuses and cutting down the patent application backlog.

The U.S. Court of Appeals for the Federal Circuit on Monday granted a combined petition by pharmaceutical firm GlaxoSmithKline PLC and inventor Triantafyllos Tafas for a rehearing en banc of the case they brought in opposition to the USPTO’s rules.

Finding that a rehearing by its full panel of judges was...
To view the full article, register now.